Dr. Altieri will be honored by the Justinian Foundation and Society of Philadelphia for exemplifying the finest qualities of scholarship, civic leadership and integrity.
“Now we know that we can use the epigenome of Epstein Barr Virus against the gastric cancer that it affects—that’s an exciting potential cancer therapy we have as a result of investigating the interplay between epigenetic patterns and disease lifecycle,” explained Tempera.
The Wistar Institute, West Philadelphia Skills Initiative, Iovance Biotherapeutics, PIDC, The Chamber of Commerce for Greater Philadelphia Launch Second Recruitment for the Award-Winning Program on August 22
